These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11723019)

  • 1. beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise.
    Ellis SG; Brener SJ; Lincoff AM; Moliterno DJ; Whitlow PL; Schneider JP; Topol EJ
    Circulation; 2001 Nov; 104(22):2685-8. PubMed ID: 11723019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction.
    Jeremias A; Albirini A; Ziada KM; Chew DP; Brener SJ; Topol EJ; Ellis SG
    Am Heart J; 2002 Jun; 143(6):1040-5. PubMed ID: 12075261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
    Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty.
    Abbas SA; Glazier JJ; Wu AH; Dupont C; Green SF; Pearsall LA; Waters DD; McKay RG
    Clin Cardiol; 1996 Oct; 19(10):782-6. PubMed ID: 8896910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
    Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
    J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival.
    Sharma SK; Kini A; Marmur JD; Fuster V
    Circulation; 2000 Jul; 102(2):166-72. PubMed ID: 10889126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different?
    Akkerhuis KM; Alexander JH; Tardiff BE; Boersma E; Harrington RA; Lincoff AM; Simoons ML
    Circulation; 2002 Feb; 105(5):554-6. PubMed ID: 11827918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
    Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
    J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
    van der Heijden DJ; Westendorp IC; Riezebos RK; Kiemeneij F; Slagboom T; van der Wieken LR; Laarman GJ
    J Am Coll Cardiol; 2004 Jul; 44(1):20-4. PubMed ID: 15234399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.
    Kornowski R; Fuchs S; Hong MK; Mehran R; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
    Catheter Cardiovasc Interv; 2000 Oct; 51(2):131-7. PubMed ID: 11025563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of direct stenting on clinical outcome in patients treated with percutaneous coronary intervention on saphenous vein graft.
    Leborgne L; Cheneau E; Pichard A; Ajani A; Pakala R; Yazdi H; Satler L; Kent K; Suddath WO; Pinnow E; Canos D; Waksman R
    Am Heart J; 2003 Sep; 146(3):501-6. PubMed ID: 12947370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality risk conferred by small elevations of creatine kinase-MB isoenzyme after percutaneous coronary intervention.
    Ioannidis JP; Karvouni E; Katritsis DG
    J Am Coll Cardiol; 2003 Oct; 42(8):1406-11. PubMed ID: 14563583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Creatine kinase-MB elevation after percutaneous coronary intervention predicts adverse outcomes in patients with acute coronary syndromes.
    Roe MT; Mahaffey KW; Kilaru R; Alexander JH; Akkerhuis KM; Simoons ML; Harrington RA; Tardiff BE; Granger CB; Ohman EM; Moliterno DJ; Lincoff AM; Armstrong PW; Van de Werf F; Califf RM; Topol EJ
    Eur Heart J; 2004 Feb; 25(4):313-21. PubMed ID: 14984920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention.
    Cai Q; Skelding KA; Armstrong AT; Desai D; Wood GC; Blankenship JC
    Am J Cardiol; 2007 Mar; 99(5):616-20. PubMed ID: 17317359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does creatine kinase-MB (CK-MB) isoenzyme elevation following percutaneous coronary intervention with drug-eluting stents impact late clinical outcome?
    Javaid A; Buch AN; Steinberg DH; Pinto Slottow T; Roy P; Pichard AD; Satler LF; Kent KM; Gevorkian N; Xue Z; Suddath WO; Waksman R
    Catheter Cardiovasc Interv; 2007 Nov; 70(6):826-31. PubMed ID: 17621656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Creatine kinase MB during myocardial infarction: relationship to preexisting coronary heart disease and medication.
    Sax H; Contesse J; Dubach P; Reinhart WH
    Acta Cardiol; 1997; 52(5):423-30. PubMed ID: 9428940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.